IL17A and colitis: In a study on DSS-induced colitis in mice, CSCC exhibited powerful anti-inflammatory effects by inhibiting the JNK1/STAT3 signaling pathway, reducing the levels of pro-inflammatory cytokines TNF-α, IL-1β, and IL-17.